BlueWhale Bio, Inc. — Form D
BlueWhale Bio, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-16. The offering totals $15.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-10-16
- Form: D
- Accession: 0001989669-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $5.0M
- Remaining: $10.0M
- Investors: 1
- Date of first sale: 2025-10-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-561155
Issuer
- Name: BlueWhale Bio, Inc.
- CIK: 0001989669
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 2929 ARCH ST, PHILADELPHIA, PA, 19104
- Phone: 617-595-7783
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Paula Cannon | Director | Philadelphia, PA |
| Elaine Heron | Director | Ann Arbor, MI |
| Peter Keller | Director | Philadelphia, PA |
| Paul Meister | Director | Waltham, MA |
| Beate Mueller-Tiemann | Director | Philadelphia, PA |
| Peter Keller | Executive Officer | Philadelphia, PA |
More